Xincheng Su - Publications

Laparoscopic versus open surgery for locally advanced gastric gastrointestinal stromal tumors following neoadjuvant imatinib therapy: a multicenter propensity-weighted cohort study.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: February 23, 2026

Study on risk stratification and treatment strategy of blood indicators in patients with moderate risk of GIST.

Journal: Frontiers in oncology

Published: November 08, 2025

The predictive value of the systemic inflammation-nutrition index for treatment response and prognosis in patients with locally advanced gastrointestinal stromal tumors receiving neoadjuvant imatinib therapy: a dual-center retrospective cohort study.

Journal: Therapeutic advances in medical oncology

Published: June 10, 2025

A novel prognostic system for locally advanced gastrointestinal stromal tumors after neoadjuvant imatinib therapy based on the metro-ticket paradigm: a retrospective dual-center study.

Journal: Surgical endoscopy

Published: May 14, 2025

Expression, Prognostic Value, and Biological Function of CENPM in Colon Adenocarcinoma.

Journal: Current medicinal chemistry

Published: February 15, 2025

Treatment research after failure of fourth-line standard therapy for advanced gastrointestinal stromal tumors: A review.

Journal: Cancer

Published: January 29, 2025

Circ_ZNF778_006 promoted ESCC progression by upregulating HIF-1α expression via sponging miR-18b-5p.

Journal: Scientific reports

Published: March 04, 2023

lncRNA-LET Regulates Glycolysis and Glutamine Decomposition of Esophageal Squamous Cell Carcinoma Through miR-93-5p/miR-106b-5p/SOCS4.

Journal: Frontiers in oncology

Published: March 16, 2022